ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 135 filers reported holding ATARA BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,828,040 | +3.2% | 8,667,594 | +12.3% | 0.00% | 0.0% |
| Q2 2023 | $12,429,607 | -44.0% | 7,720,253 | +0.8% | 0.00% | -66.7% |
| Q1 2023 | $22,201,000 | +90151.6% | 7,655,769 | +2.1% | 0.00% | 0.0% |
| Q4 2022 | $24,599 | -99.9% | 7,499,435 | -9.5% | 0.00% | -25.0% |
| Q3 2022 | $31,312,000 | -54.6% | 8,283,388 | -6.5% | 0.00% | -60.0% |
| Q2 2022 | $69,029,000 | -9.3% | 8,861,252 | +8.2% | 0.01% | +11.1% |
| Q1 2022 | $76,085,000 | -34.9% | 8,189,899 | +10.4% | 0.01% | -30.8% |
| Q4 2021 | $116,894,000 | -18.5% | 7,417,122 | -7.5% | 0.01% | -27.8% |
| Q3 2021 | $143,483,000 | +22.8% | 8,015,817 | +6.7% | 0.02% | +28.6% |
| Q2 2021 | $116,852,000 | +21.3% | 7,514,562 | +12.0% | 0.01% | +7.7% |
| Q1 2021 | $96,332,000 | -20.9% | 6,708,372 | +8.1% | 0.01% | -27.8% |
| Q4 2020 | $121,858,000 | +67.0% | 6,207,767 | +11.3% | 0.02% | +50.0% |
| Q3 2020 | $72,969,000 | +20.5% | 5,578,675 | +34.3% | 0.01% | 0.0% |
| Q2 2020 | $60,539,000 | +147.8% | 4,155,030 | +44.8% | 0.01% | +100.0% |
| Q1 2020 | $24,427,000 | -44.5% | 2,870,248 | +7.5% | 0.01% | -25.0% |
| Q4 2019 | $43,974,000 | +20.7% | 2,669,931 | +3.4% | 0.01% | +14.3% |
| Q3 2019 | $36,447,000 | -4.3% | 2,581,293 | +37.2% | 0.01% | 0.0% |
| Q2 2019 | $38,102,000 | -50.0% | 1,881,642 | -1.9% | 0.01% | -56.2% |
| Q1 2019 | $76,237,000 | +76.0% | 1,917,903 | +53.8% | 0.02% | +60.0% |
| Q4 2018 | $43,310,000 | -12.9% | 1,246,687 | +3.6% | 0.01% | 0.0% |
| Q3 2018 | $49,741,000 | +52.6% | 1,202,912 | +35.6% | 0.01% | +42.9% |
| Q2 2018 | $32,597,000 | +12534.5% | 886,991 | +13288.5% | 0.01% | – |
| Q1 2018 | $258,000 | +148.1% | 6,625 | +14.8% | 0.00% | – |
| Q4 2017 | $104,000 | -94.9% | 5,769 | -93.6% | 0.00% | -100.0% |
| Q2 2016 | $2,029,000 | +70.4% | 90,135 | +44.0% | 0.00% | – |
| Q1 2016 | $1,191,000 | -25.7% | 62,600 | +3.1% | 0.00% | – |
| Q4 2015 | $1,603,000 | -71.0% | 60,700 | -65.5% | 0.00% | -100.0% |
| Q3 2015 | $5,534,000 | -47.7% | 176,046 | -12.3% | 0.00% | -50.0% |
| Q2 2015 | $10,589,000 | +76.7% | 200,700 | +39.2% | 0.00% | +100.0% |
| Q1 2015 | $5,993,000 | +49.1% | 144,150 | -4.1% | 0.00% | 0.0% |
| Q4 2014 | $4,019,000 | – | 150,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $1,480,000 | 7.58% |
| Redmile Group, LLC | 6,280,813 | $9,295,603 | 0.44% |
| Arctis Global LLC | 397,046 | $587,628 | 0.32% |
| Baupost Group | 9,773,616 | $14,465 | 0.28% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 230,000 | $413,400 | 0.24% |
| MAVERICK CAPITAL LTD | 6,290,713 | $9,310,255 | 0.21% |
| 683 Capital Management, LLC | 1,200,000 | $1,776,000 | 0.14% |
| STALEY CAPITAL ADVISERS INC | 1,000,000 | $1,480,000 | 0.08% |
| WASATCH ADVISORS LP | 8,399,229 | $12,430,859 | 0.08% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $777,000 | 0.07% |